SQUASSINA, ALESSIO
 Distribuzione geografica
Continente #
EU - Europa 186.535
NA - Nord America 7.242
AS - Asia 1.210
AF - Africa 15
SA - Sud America 14
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 195.028
Nazione #
IT - Italia 184.833
US - Stati Uniti d'America 7.191
CN - Cina 781
UA - Ucraina 499
SE - Svezia 456
DE - Germania 243
SG - Singapore 188
FI - Finlandia 173
GB - Regno Unito 159
VN - Vietnam 89
IN - India 50
CA - Canada 45
FR - Francia 42
KR - Corea 24
BE - Belgio 23
HK - Hong Kong 18
IE - Irlanda 17
RU - Federazione Russa 15
TR - Turchia 15
NL - Olanda 14
CZ - Repubblica Ceca 13
IR - Iran 13
ES - Italia 12
AU - Australia 11
BR - Brasile 11
CH - Svizzera 8
JP - Giappone 6
MX - Messico 6
GR - Grecia 5
ID - Indonesia 5
IL - Israele 4
PL - Polonia 4
CI - Costa d'Avorio 3
HR - Croazia 3
MY - Malesia 3
NG - Nigeria 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
EG - Egitto 2
IS - Islanda 2
MA - Marocco 2
MG - Madagascar 2
NP - Nepal 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
TZ - Tanzania 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
EU - Europa 1
KH - Cambogia 1
LI - Liechtenstein 1
MD - Moldavia 1
MK - Macedonia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 195.028
Città #
Cagliari 184.220
Fairfield 1.063
Woodbridge 765
Chandler 647
Ashburn 512
Houston 512
Seattle 412
Wilmington 386
Nyköping 348
Ann Arbor 340
Cambridge 334
Jacksonville 241
Dearborn 175
New York 167
Shanghai 139
Boardman 136
Beijing 101
Helsinki 101
Nanjing 98
Boston 93
Dong Ket 89
Singapore 72
San Diego 60
Rome 56
Redwood City 49
Norwalk 47
Shenyang 34
Guangzhou 33
Hebei 33
London 33
Nanchang 32
Atlanta 30
Jiaxing 30
Milan 25
Brussels 21
Changsha 21
Mountain View 21
Toronto 20
Seoul 19
Pune 18
Los Angeles 17
Orange 17
Redmond 17
Tianjin 17
Berlin 16
Clarks Summit 16
Sassari 16
Zhengzhou 16
Chennai 15
Verona 15
Auburn Hills 14
Hangzhou 14
Hefei 14
San Francisco 13
Washington 13
Dublin 12
Falls Church 11
Kunming 11
Arlington 10
Brno 10
Brunswick 10
Olbia 10
Phoenix 10
San Mateo 10
Ningbo 9
Jinan 8
Paris 8
San Sperate 8
Wuhan 8
Boydton 7
Hong Kong 7
Lambeth 7
Millbury 7
Ardabil 6
Chicago 6
Istanbul 6
Leawood 6
Saint Petersburg 6
Serramanna 6
Shenzhen 6
Genoa 5
Monmouth Junction 5
Parma 5
Qingdao 5
Quartu Sant'Elena 5
Richmond 5
Selargius 5
Shaoxing 5
Suni 5
Amsterdam 4
Augusta 4
Baoding 4
Bologna 4
Chengdu 4
Council Bluffs 4
Edmonton 4
Fuzhou 4
Guasila 4
Hounslow 4
Konya 4
Totale 192.057
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.079
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 3.602
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.056
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 2.897
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 2.895
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 2.817
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 2.780
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 2.747
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 2.732
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 2.682
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.669
Challenges and Future Prospects of Precision Medicine in Psychiatry 2.639
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study 2.612
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 2.595
Analysis of the influence of microRNAs in lithium response in bipolar disorder 2.548
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study 2.528
Differential effect of lithium on spermidine/spermine N1-acetiltransferase expression in suicidal behaviour 2.528
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.505
null 2.498
Involvement of core clock genes in lithium response 2.498
Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder. A genome-wide association study 2.463
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.439
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.428
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder 2.422
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.389
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients 2.382
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder 2.283
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.187
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.179
Pharmacogenomics of bipolar disorder 2.179
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.087
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.073
Lithium pharmacogenetics: Where do we stand? 2.072
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 2.022
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? 2.012
null 1.980
Novel integrative genomic tool for interrogating lithium response in bipolar disorder 1.916
Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene 1.904
Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample 1.875
null 1.842
An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes 1.804
Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report 1.748
Lithium pharmacogenetics 1.730
Variant GADL1 and response to lithium in bipolar I disorder 1.729
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.719
Cellular models to study bipolar disorder: a systematic review 1.620
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.620
Doctors and researchers: integrating data for bipolar disorder studies 1.600
The international consortium on lithium genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment 1.600
557. Pharmacogenetic Association of Lithium Treatment Response with Bcl2 Polymorphism in Bipolar Disorder 1.576
Positive Association Between REV-ERB Alpha Gene and Bipolar Disorder in a Sardinian Population 1.570
Zinc finger proteins in psychiatric disorders and response to psychotropic medications 1.543
null 1.525
A genetic risk score is differentially associated with migraine with and without aura 1.505
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 1.499
Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine. 1.491
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder 1.489
Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients 1.454
null 1.449
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches 1.441
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 1.439
null 1.424
null 1.414
Leukocyte telomere length is reduced in patients with major depressive disorder 1.392
We are not alone in our body: insights into the involvement of microbiota in the etiopathogenesis and pharmacology of mental illness 1.378
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.323
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment 1.305
A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample 1.258
Characterisation of age and polarity at onset in bipolar disorder 1.249
Candidate Genes in Bipolar 1 Sradinian Patients : A case control Study 1.244
Prediction of lithium response using genomic data 1.213
null 1.161
null 1.156
Telomere length in bipolar disorder and lithium response 1.156
null 1.146
RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining 1.130
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.122
RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium clinical efficacy 1.113
Assessment of the pharmacogenomics educational environment in southeast europe 1.056
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine 1.049
Haplotype association study between DRD1 gene and parasuicide in bipolar disorder: Analysis of two samples from Canada and Sardinia 1.039
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 1.020
Alzheimer’s disease: case-control study of polymorphisms in ACHE, CHAT and BCHE genes in a Sardininan sample 967
Candidate Genes in Bipolar 1 Sardinian Patients : A case control Study 921
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 917
Genetic, demographic and archival study on a Sardinian village (Escalaplano) Italy 909
Genetically elevated high-density lipoprotein cholesterol through cholesteryl ester transfer protein does not associate with risk of Alzheimer's disease 904
An introduction to pharmacogenomics and personalized medicine 903
Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders 881
2016 Golden Helix Summer School - Cancer Genomics and Individualized Therapy. 22-26 September 2016, Syros Island, Greece: Abstracts 877
Association analyses of PDLIM5 gene in bipolar disorder 842
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy 832
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 807
M. Alzheimer’s disease: case-control study of polymorphisms in ACHE, CHAT and BCHE genes in a Sardininan sample 761
Realities and expectations of pharmacogenomics and personalized medicine: Impact of translating genetic knowledge into clinical practice 755
Pharmacogenomics and Personalized Medicine: Bridging Genetic Knowledge and Clinical Practice 710
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patiens 685
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 667
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 653
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 652
Totale 172.183
Categoria #
all - tutte 235.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 235.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031.705 0 849 240 497 12.389 8.551 4.750 1.057 775 636 687 1.274
2020/202154.780 1.558 2.045 1.957 14.275 10.398 6.321 4.076 3.800 1.596 3.166 3.426 2.162
2021/202214.228 1.839 965 810 1.128 1.149 840 868 680 1.363 1.464 1.732 1.390
2022/202320.269 1.298 2.583 2.690 1.780 1.547 2.277 977 1.292 1.482 1.494 1.874 975
2023/202420.567 915 746 795 1.387 1.949 3.193 3.207 1.447 981 1.349 2.332 2.266
2024/202518.630 16.213 2.417 0 0 0 0 0 0 0 0 0 0
Totale 195.666